Vitale, S.G.; Laganà , A.S.; Capriglione, S.; Angioli, R.; La Rosa, V.L.; Lopez, S.; Valenti, G.; Sapia, F.; Sarpietro, G.; Butticè, S.;
et al. Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives. Int. J. Mol. Sci. 2017, 18, 1100.
https://doi.org/10.3390/ijms18051100
AMA Style
Vitale SG, Laganà AS, Capriglione S, Angioli R, La Rosa VL, Lopez S, Valenti G, Sapia F, Sarpietro G, Butticè S,
et al. Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives. International Journal of Molecular Sciences. 2017; 18(5):1100.
https://doi.org/10.3390/ijms18051100
Chicago/Turabian Style
Vitale, Salvatore Giovanni, Antonio Simone Laganà , Stella Capriglione, Roberto Angioli, Valentina Lucia La Rosa, Salvatore Lopez, Gaetano Valenti, Fabrizio Sapia, Giuseppe Sarpietro, Salvatore Butticè,
and et al. 2017. "Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives" International Journal of Molecular Sciences 18, no. 5: 1100.
https://doi.org/10.3390/ijms18051100
APA Style
Vitale, S. G., Laganà , A. S., Capriglione, S., Angioli, R., La Rosa, V. L., Lopez, S., Valenti, G., Sapia, F., Sarpietro, G., Butticè, S., Tuscano, C., Fanale, D., Tropea, A., & Rossetti, D.
(2017). Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives. International Journal of Molecular Sciences, 18(5), 1100.
https://doi.org/10.3390/ijms18051100